0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pyrazinamide Tablets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0A14757
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pyrazinamide Tablets Market Research Report 2023
BUY CHAPTERS

Global Pyrazinamide Tablets Market Research Report 2025

Code: QYRE-Auto-0A14757
Report
May 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pyrazinamide Tablets Market

The global market for Pyrazinamide Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pyrazinamide Tablets, indicated to be effective against mycobacterium only, are used in combination with other antituberculosis agents such as streptomycin, isoniazid, rifampicin and ethambutol to treat tuberculosis.
North American market for Pyrazinamide Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pyrazinamide Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pyrazinamide Tablets include Akorn Operating, Healthy Life Pharma, Wellona Pharma, Lupin, Akorn, Cadila Pharmaceuticals, Macleods Pharma, Morningside Healthcare, Datong Liqun Pharmaceutical, Guangdong Taicheng Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pyrazinamide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pyrazinamide Tablets.
The Pyrazinamide Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Boxes) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pyrazinamide Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pyrazinamide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pyrazinamide Tablets Market Report

Report Metric Details
Report Name Pyrazinamide Tablets Market
Segment by Type
  • 0.5g/Tablet
  • 0.25g/Tablet
Segment by Application
  • Hospital
  • Clinic
  • Drugstore
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Akorn Operating, Healthy Life Pharma, Wellona Pharma, Lupin, Akorn, Cadila Pharmaceuticals, Macleods Pharma, Morningside Healthcare, Datong Liqun Pharmaceutical, Guangdong Taicheng Pharmaceutical, Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical), Changchun Maoshun Pharmaceutical, Jiangsu Sihuan Bioengineering Pharmaceutical, Chongqing Huapont Pharmaceutical, Suzhou Homesun Pharmaceutical, Chengdu Jinhua Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pyrazinamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pyrazinamide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pyrazinamide Tablets Market report?

Ans: The main players in the Pyrazinamide Tablets Market are Akorn Operating, Healthy Life Pharma, Wellona Pharma, Lupin, Akorn, Cadila Pharmaceuticals, Macleods Pharma, Morningside Healthcare, Datong Liqun Pharmaceutical, Guangdong Taicheng Pharmaceutical, Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical), Changchun Maoshun Pharmaceutical, Jiangsu Sihuan Bioengineering Pharmaceutical, Chongqing Huapont Pharmaceutical, Suzhou Homesun Pharmaceutical, Chengdu Jinhua Pharmaceutical

What are the Application segmentation covered in the Pyrazinamide Tablets Market report?

Ans: The Applications covered in the Pyrazinamide Tablets Market report are Hospital, Clinic, Drugstore

What are the Type segmentation covered in the Pyrazinamide Tablets Market report?

Ans: The Types covered in the Pyrazinamide Tablets Market report are 0.5g/Tablet, 0.25g/Tablet

Recommended Reports

Tuberculosis Drug Markets

Generic Tablets Market

API & Drug Ingredients

1 Pyrazinamide Tablets Market Overview
1.1 Product Definition
1.2 Pyrazinamide Tablets by Type
1.2.1 Global Pyrazinamide Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5g/Tablet
1.2.3 0.25g/Tablet
1.3 Pyrazinamide Tablets by Application
1.3.1 Global Pyrazinamide Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Pyrazinamide Tablets Market Size Estimates and Forecasts
1.4.1 Global Pyrazinamide Tablets Revenue 2020-2031
1.4.2 Global Pyrazinamide Tablets Sales 2020-2031
1.4.3 Global Pyrazinamide Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pyrazinamide Tablets Market Competition by Manufacturers
2.1 Global Pyrazinamide Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pyrazinamide Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pyrazinamide Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pyrazinamide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pyrazinamide Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pyrazinamide Tablets, Product Type & Application
2.7 Global Key Manufacturers of Pyrazinamide Tablets, Date of Enter into This Industry
2.8 Global Pyrazinamide Tablets Market Competitive Situation and Trends
2.8.1 Global Pyrazinamide Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pyrazinamide Tablets Players Market Share by Revenue
2.8.3 Global Pyrazinamide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pyrazinamide Tablets Market Scenario by Region
3.1 Global Pyrazinamide Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pyrazinamide Tablets Sales by Region: 2020-2031
3.2.1 Global Pyrazinamide Tablets Sales by Region: 2020-2025
3.2.2 Global Pyrazinamide Tablets Sales by Region: 2026-2031
3.3 Global Pyrazinamide Tablets Revenue by Region: 2020-2031
3.3.1 Global Pyrazinamide Tablets Revenue by Region: 2020-2025
3.3.2 Global Pyrazinamide Tablets Revenue by Region: 2026-2031
3.4 North America Pyrazinamide Tablets Market Facts & Figures by Country
3.4.1 North America Pyrazinamide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pyrazinamide Tablets Sales by Country (2020-2031)
3.4.3 North America Pyrazinamide Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pyrazinamide Tablets Market Facts & Figures by Country
3.5.1 Europe Pyrazinamide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pyrazinamide Tablets Sales by Country (2020-2031)
3.5.3 Europe Pyrazinamide Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pyrazinamide Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Pyrazinamide Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pyrazinamide Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Pyrazinamide Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pyrazinamide Tablets Market Facts & Figures by Country
3.7.1 Latin America Pyrazinamide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pyrazinamide Tablets Sales by Country (2020-2031)
3.7.3 Latin America Pyrazinamide Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pyrazinamide Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Pyrazinamide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pyrazinamide Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pyrazinamide Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pyrazinamide Tablets Sales by Type (2020-2031)
4.1.1 Global Pyrazinamide Tablets Sales by Type (2020-2025)
4.1.2 Global Pyrazinamide Tablets Sales by Type (2026-2031)
4.1.3 Global Pyrazinamide Tablets Sales Market Share by Type (2020-2031)
4.2 Global Pyrazinamide Tablets Revenue by Type (2020-2031)
4.2.1 Global Pyrazinamide Tablets Revenue by Type (2020-2025)
4.2.2 Global Pyrazinamide Tablets Revenue by Type (2026-2031)
4.2.3 Global Pyrazinamide Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Pyrazinamide Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pyrazinamide Tablets Sales by Application (2020-2031)
5.1.1 Global Pyrazinamide Tablets Sales by Application (2020-2025)
5.1.2 Global Pyrazinamide Tablets Sales by Application (2026-2031)
5.1.3 Global Pyrazinamide Tablets Sales Market Share by Application (2020-2031)
5.2 Global Pyrazinamide Tablets Revenue by Application (2020-2031)
5.2.1 Global Pyrazinamide Tablets Revenue by Application (2020-2025)
5.2.2 Global Pyrazinamide Tablets Revenue by Application (2026-2031)
5.2.3 Global Pyrazinamide Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Pyrazinamide Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Akorn Operating
6.1.1 Akorn Operating Company Information
6.1.2 Akorn Operating Description and Business Overview
6.1.3 Akorn Operating Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Akorn Operating Pyrazinamide Tablets Product Portfolio
6.1.5 Akorn Operating Recent Developments/Updates
6.2 Healthy Life Pharma
6.2.1 Healthy Life Pharma Company Information
6.2.2 Healthy Life Pharma Description and Business Overview
6.2.3 Healthy Life Pharma Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Healthy Life Pharma Pyrazinamide Tablets Product Portfolio
6.2.5 Healthy Life Pharma Recent Developments/Updates
6.3 Wellona Pharma
6.3.1 Wellona Pharma Company Information
6.3.2 Wellona Pharma Description and Business Overview
6.3.3 Wellona Pharma Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Wellona Pharma Pyrazinamide Tablets Product Portfolio
6.3.5 Wellona Pharma Recent Developments/Updates
6.4 Lupin
6.4.1 Lupin Company Information
6.4.2 Lupin Description and Business Overview
6.4.3 Lupin Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lupin Pyrazinamide Tablets Product Portfolio
6.4.5 Lupin Recent Developments/Updates
6.5 Akorn
6.5.1 Akorn Company Information
6.5.2 Akorn Description and Business Overview
6.5.3 Akorn Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Akorn Pyrazinamide Tablets Product Portfolio
6.5.5 Akorn Recent Developments/Updates
6.6 Cadila Pharmaceuticals
6.6.1 Cadila Pharmaceuticals Company Information
6.6.2 Cadila Pharmaceuticals Description and Business Overview
6.6.3 Cadila Pharmaceuticals Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cadila Pharmaceuticals Pyrazinamide Tablets Product Portfolio
6.6.5 Cadila Pharmaceuticals Recent Developments/Updates
6.7 Macleods Pharma
6.7.1 Macleods Pharma Company Information
6.7.2 Macleods Pharma Description and Business Overview
6.7.3 Macleods Pharma Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Macleods Pharma Pyrazinamide Tablets Product Portfolio
6.7.5 Macleods Pharma Recent Developments/Updates
6.8 Morningside Healthcare
6.8.1 Morningside Healthcare Company Information
6.8.2 Morningside Healthcare Description and Business Overview
6.8.3 Morningside Healthcare Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Morningside Healthcare Pyrazinamide Tablets Product Portfolio
6.8.5 Morningside Healthcare Recent Developments/Updates
6.9 Datong Liqun Pharmaceutical
6.9.1 Datong Liqun Pharmaceutical Company Information
6.9.2 Datong Liqun Pharmaceutical Description and Business Overview
6.9.3 Datong Liqun Pharmaceutical Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Datong Liqun Pharmaceutical Pyrazinamide Tablets Product Portfolio
6.9.5 Datong Liqun Pharmaceutical Recent Developments/Updates
6.10 Guangdong Taicheng Pharmaceutical
6.10.1 Guangdong Taicheng Pharmaceutical Company Information
6.10.2 Guangdong Taicheng Pharmaceutical Description and Business Overview
6.10.3 Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Product Portfolio
6.10.5 Guangdong Taicheng Pharmaceutical Recent Developments/Updates
6.11 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical)
6.11.1 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Company Information
6.11.2 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Description and Business Overview
6.11.3 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Product Portfolio
6.11.5 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Recent Developments/Updates
6.12 Changchun Maoshun Pharmaceutical
6.12.1 Changchun Maoshun Pharmaceutical Company Information
6.12.2 Changchun Maoshun Pharmaceutical Description and Business Overview
6.12.3 Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Product Portfolio
6.12.5 Changchun Maoshun Pharmaceutical Recent Developments/Updates
6.13 Jiangsu Sihuan Bioengineering Pharmaceutical
6.13.1 Jiangsu Sihuan Bioengineering Pharmaceutical Company Information
6.13.2 Jiangsu Sihuan Bioengineering Pharmaceutical Description and Business Overview
6.13.3 Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Product Portfolio
6.13.5 Jiangsu Sihuan Bioengineering Pharmaceutical Recent Developments/Updates
6.14 Chongqing Huapont Pharmaceutical
6.14.1 Chongqing Huapont Pharmaceutical Company Information
6.14.2 Chongqing Huapont Pharmaceutical Description and Business Overview
6.14.3 Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Product Portfolio
6.14.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
6.15 Suzhou Homesun Pharmaceutical
6.15.1 Suzhou Homesun Pharmaceutical Company Information
6.15.2 Suzhou Homesun Pharmaceutical Description and Business Overview
6.15.3 Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Product Portfolio
6.15.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
6.16 Chengdu Jinhua Pharmaceutical
6.16.1 Chengdu Jinhua Pharmaceutical Company Information
6.16.2 Chengdu Jinhua Pharmaceutical Description and Business Overview
6.16.3 Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Product Portfolio
6.16.5 Chengdu Jinhua Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pyrazinamide Tablets Industry Chain Analysis
7.2 Pyrazinamide Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pyrazinamide Tablets Production Mode & Process Analysis
7.4 Pyrazinamide Tablets Sales and Marketing
7.4.1 Pyrazinamide Tablets Sales Channels
7.4.2 Pyrazinamide Tablets Distributors
7.5 Pyrazinamide Tablets Customer Analysis
8 Pyrazinamide Tablets Market Dynamics
8.1 Pyrazinamide Tablets Industry Trends
8.2 Pyrazinamide Tablets Market Drivers
8.3 Pyrazinamide Tablets Market Challenges
8.4 Pyrazinamide Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pyrazinamide Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pyrazinamide Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pyrazinamide Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pyrazinamide Tablets Sales (K Boxes) of Key Manufacturers (2020-2025)
 Table 5. Global Pyrazinamide Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pyrazinamide Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pyrazinamide Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pyrazinamide Tablets Average Price (US$/Box) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pyrazinamide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pyrazinamide Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pyrazinamide Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Pyrazinamide Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pyrazinamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pyrazinamide Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pyrazinamide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pyrazinamide Tablets Sales by Region (2020-2025) & (K Boxes)
 Table 18. Global Pyrazinamide Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Pyrazinamide Tablets Sales by Region (2026-2031) & (K Boxes)
 Table 20. Global Pyrazinamide Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Pyrazinamide Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pyrazinamide Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Pyrazinamide Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pyrazinamide Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Pyrazinamide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pyrazinamide Tablets Sales by Country (2020-2025) & (K Boxes)
 Table 27. North America Pyrazinamide Tablets Sales by Country (2026-2031) & (K Boxes)
 Table 28. North America Pyrazinamide Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pyrazinamide Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pyrazinamide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pyrazinamide Tablets Sales by Country (2020-2025) & (K Boxes)
 Table 32. Europe Pyrazinamide Tablets Sales by Country (2026-2031) & (K Boxes)
 Table 33. Europe Pyrazinamide Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pyrazinamide Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pyrazinamide Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pyrazinamide Tablets Sales by Region (2020-2025) & (K Boxes)
 Table 37. Asia Pacific Pyrazinamide Tablets Sales by Region (2026-2031) & (K Boxes)
 Table 38. Asia Pacific Pyrazinamide Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pyrazinamide Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pyrazinamide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pyrazinamide Tablets Sales by Country (2020-2025) & (K Boxes)
 Table 42. Latin America Pyrazinamide Tablets Sales by Country (2026-2031) & (K Boxes)
 Table 43. Latin America Pyrazinamide Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pyrazinamide Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pyrazinamide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pyrazinamide Tablets Sales by Country (2020-2025) & (K Boxes)
 Table 47. Middle East and Africa Pyrazinamide Tablets Sales by Country (2026-2031) & (K Boxes)
 Table 48. Middle East and Africa Pyrazinamide Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pyrazinamide Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pyrazinamide Tablets Sales (K Boxes) by Type (2020-2025)
 Table 51. Global Pyrazinamide Tablets Sales (K Boxes) by Type (2026-2031)
 Table 52. Global Pyrazinamide Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Pyrazinamide Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Pyrazinamide Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pyrazinamide Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pyrazinamide Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Pyrazinamide Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Pyrazinamide Tablets Price (US$/Box) by Type (2020-2025)
 Table 59. Global Pyrazinamide Tablets Price (US$/Box) by Type (2026-2031)
 Table 60. Global Pyrazinamide Tablets Sales (K Boxes) by Application (2020-2025)
 Table 61. Global Pyrazinamide Tablets Sales (K Boxes) by Application (2026-2031)
 Table 62. Global Pyrazinamide Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Pyrazinamide Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Pyrazinamide Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pyrazinamide Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pyrazinamide Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Pyrazinamide Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Pyrazinamide Tablets Price (US$/Box) by Application (2020-2025)
 Table 69. Global Pyrazinamide Tablets Price (US$/Box) by Application (2026-2031)
 Table 70. Akorn Operating Company Information
 Table 71. Akorn Operating Description and Business Overview
 Table 72. Akorn Operating Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 73. Akorn Operating Pyrazinamide Tablets Product
 Table 74. Akorn Operating Recent Developments/Updates
 Table 75. Healthy Life Pharma Company Information
 Table 76. Healthy Life Pharma Description and Business Overview
 Table 77. Healthy Life Pharma Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 78. Healthy Life Pharma Pyrazinamide Tablets Product
 Table 79. Healthy Life Pharma Recent Developments/Updates
 Table 80. Wellona Pharma Company Information
 Table 81. Wellona Pharma Description and Business Overview
 Table 82. Wellona Pharma Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 83. Wellona Pharma Pyrazinamide Tablets Product
 Table 84. Wellona Pharma Recent Developments/Updates
 Table 85. Lupin Company Information
 Table 86. Lupin Description and Business Overview
 Table 87. Lupin Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 88. Lupin Pyrazinamide Tablets Product
 Table 89. Lupin Recent Developments/Updates
 Table 90. Akorn Company Information
 Table 91. Akorn Description and Business Overview
 Table 92. Akorn Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 93. Akorn Pyrazinamide Tablets Product
 Table 94. Akorn Recent Developments/Updates
 Table 95. Cadila Pharmaceuticals Company Information
 Table 96. Cadila Pharmaceuticals Description and Business Overview
 Table 97. Cadila Pharmaceuticals Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 98. Cadila Pharmaceuticals Pyrazinamide Tablets Product
 Table 99. Cadila Pharmaceuticals Recent Developments/Updates
 Table 100. Macleods Pharma Company Information
 Table 101. Macleods Pharma Description and Business Overview
 Table 102. Macleods Pharma Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 103. Macleods Pharma Pyrazinamide Tablets Product
 Table 104. Macleods Pharma Recent Developments/Updates
 Table 105. Morningside Healthcare Company Information
 Table 106. Morningside Healthcare Description and Business Overview
 Table 107. Morningside Healthcare Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 108. Morningside Healthcare Pyrazinamide Tablets Product
 Table 109. Morningside Healthcare Recent Developments/Updates
 Table 110. Datong Liqun Pharmaceutical Company Information
 Table 111. Datong Liqun Pharmaceutical Description and Business Overview
 Table 112. Datong Liqun Pharmaceutical Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 113. Datong Liqun Pharmaceutical Pyrazinamide Tablets Product
 Table 114. Datong Liqun Pharmaceutical Recent Developments/Updates
 Table 115. Guangdong Taicheng Pharmaceutical Company Information
 Table 116. Guangdong Taicheng Pharmaceutical Description and Business Overview
 Table 117. Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 118. Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Product
 Table 119. Guangdong Taicheng Pharmaceutical Recent Developments/Updates
 Table 120. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Company Information
 Table 121. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Description and Business Overview
 Table 122. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 123. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Product
 Table 124. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Recent Developments/Updates
 Table 125. Changchun Maoshun Pharmaceutical Company Information
 Table 126. Changchun Maoshun Pharmaceutical Description and Business Overview
 Table 127. Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 128. Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Product
 Table 129. Changchun Maoshun Pharmaceutical Recent Developments/Updates
 Table 130. Jiangsu Sihuan Bioengineering Pharmaceutical Company Information
 Table 131. Jiangsu Sihuan Bioengineering Pharmaceutical Description and Business Overview
 Table 132. Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 133. Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Product
 Table 134. Jiangsu Sihuan Bioengineering Pharmaceutical Recent Developments/Updates
 Table 135. Chongqing Huapont Pharmaceutical Company Information
 Table 136. Chongqing Huapont Pharmaceutical Description and Business Overview
 Table 137. Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 138. Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Product
 Table 139. Chongqing Huapont Pharmaceutical Recent Developments/Updates
 Table 140. Suzhou Homesun Pharmaceutical Company Information
 Table 141. Suzhou Homesun Pharmaceutical Description and Business Overview
 Table 142. Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 143. Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Product
 Table 144. Suzhou Homesun Pharmaceutical Recent Developments/Updates
 Table 145. Chengdu Jinhua Pharmaceutical Company Information
 Table 146. Chengdu Jinhua Pharmaceutical Description and Business Overview
 Table 147. Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 148. Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Product
 Table 149. Chengdu Jinhua Pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Pyrazinamide Tablets Distributors List
 Table 153. Pyrazinamide Tablets Customers List
 Table 154. Pyrazinamide Tablets Market Trends
 Table 155. Pyrazinamide Tablets Market Drivers
 Table 156. Pyrazinamide Tablets Market Challenges
 Table 157. Pyrazinamide Tablets Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pyrazinamide Tablets
 Figure 2. Global Pyrazinamide Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pyrazinamide Tablets Market Share by Type: 2024 & 2031
 Figure 4. 0.5g/Tablet Product Picture
 Figure 5. 0.25g/Tablet Product Picture
 Figure 6. Global Pyrazinamide Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pyrazinamide Tablets Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Drugstore
 Figure 11. Global Pyrazinamide Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pyrazinamide Tablets Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Pyrazinamide Tablets Sales (2020-2031) & (K Boxes)
 Figure 14. Global Pyrazinamide Tablets Average Price (US$/Box) & (2020-2031)
 Figure 15. Pyrazinamide Tablets Report Years Considered
 Figure 16. Pyrazinamide Tablets Sales Share by Manufacturers in 2024
 Figure 17. Global Pyrazinamide Tablets Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Pyrazinamide Tablets Players: Market Share by Revenue in Pyrazinamide Tablets in 2024
 Figure 19. Pyrazinamide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Pyrazinamide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Pyrazinamide Tablets Sales Market Share by Country (2020-2031)
 Figure 22. North America Pyrazinamide Tablets Revenue Market Share by Country (2020-2031)
 Figure 23. United States Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Pyrazinamide Tablets Sales Market Share by Country (2020-2031)
 Figure 26. Europe Pyrazinamide Tablets Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Pyrazinamide Tablets Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Pyrazinamide Tablets Revenue Market Share by Region (2020-2031)
 Figure 34. China Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Pyrazinamide Tablets Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Pyrazinamide Tablets Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Pyrazinamide Tablets Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Pyrazinamide Tablets Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Pyrazinamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Pyrazinamide Tablets by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Pyrazinamide Tablets by Type (2020-2031)
 Figure 53. Global Pyrazinamide Tablets Price (US$/Box) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Pyrazinamide Tablets by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Pyrazinamide Tablets by Application (2020-2031)
 Figure 56. Global Pyrazinamide Tablets Price (US$/Box) by Application (2020-2031)
 Figure 57. Pyrazinamide Tablets Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure